Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature

2019 ◽  
Vol 110 (4) ◽  
Author(s):  
Salvatore Gueli Alletti ◽  
Vito A. Capozzi ◽  
Andrea Rosati ◽  
Ilaria De Blasis ◽  
Stefano Cianci ◽  
...  
Keyword(s):  
Systematic Review ◽  
Ovarian Cancer ◽  
Advanced Ovarian Cancer ◽  
Review Of The Literature

scholarly journals Vitamin D and Ovarian Cancer: Systematic Review of the Literature with a Focus on Molecular Mechanisms

Cells ◽  
2020 ◽  
Vol 9 (2) ◽  
pp. 335 ◽  
Author(s):  
Andraž Dovnik ◽  
Nina Fokter Dovnik
Keyword(s):  
Systematic Review ◽  
Ovarian Cancer ◽  
Vitamin D ◽  
Cancer Cell ◽  
Cancer Progression ◽  
Molecular Mechanisms ◽  
Vitamin D Supplementation ◽  
Review Of The Literature ◽  
Epidemiologic Evidence ◽  
Vitamin D Levels

Vitamin D is a lipid soluble vitamin involved primarily in calcium metabolism. Epidemiologic evidence indicates that lower circulating vitamin D levels are associated with a higher risk of ovarian cancer and that vitamin D supplementation is associated with decreased cancer mortality. A vast amount of research exists on the possible molecular mechanisms through which vitamin D affects cancer cell proliferation, cancer progression, angiogenesis, and inflammation. We conducted a systematic review of the literature on the effects of vitamin D on ovarian cancer cell.

HIPEC in patients with primary advanced ovarian cancer: Is there a role? A systematic review of short- and long-term outcomes

2018 ◽  
Vol 27 (2) ◽  
pp. 251-258 ◽  
Author(s):  
G.S. Kireeva ◽  
G.I. Gafton ◽  
K.D. Guseynov ◽  
K.Y. Senchik ◽  
O.A. Belyaeva ◽  
...  
Keyword(s):  
Systematic Review ◽  
Ovarian Cancer ◽  
Advanced Ovarian Cancer ◽  
Long Term Outcomes ◽  
Short And Long Term

Fatal pulmonary fibrosis induced by paclitaxel: a case report and review of the literature

2006 ◽  
Vol 16 (Suppl 1) ◽  
pp. 391-393 ◽  
Author(s):  
G. Ostoros ◽  
A. Pretz ◽  
J. Fillinger ◽  
I. Soltesz ◽  
B. Dome
Keyword(s):  
Ovarian Cancer ◽  
Case Report ◽  
Respiratory Failure ◽  
Pulmonary Fibrosis ◽  
Combination Chemotherapy ◽  
Interstitial Pneumonitis ◽  
Lung Fibrosis ◽  
Fatal Outcome ◽  
Advanced Ovarian Cancer ◽  
Review Of The Literature

Fatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62-year-old woman who received six cycles of paclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer. Four weeks after the end of the chemotherapy she developed interstitial pneumonitis and irreversible lung fibrosis. Despite treatment with corticosteroids, she had rapid deterioration and died of respiratory failure. Pulmonary fibrosis is a complication of paclitaxel therapy that may occur despite treatments with corticosteroids. While reviewing the literature, we found few less severe pulmonary injuries after intravenous use of paclitaxel, but none of these cases had a fatal outcome. Physicians should keep in mind that taxanes such as paclitaxel have the potential to cause pneumonitis and lung fibrosis.

Sign in / Sign up

Export Citation Format

Share Document